title: Deoxygenation-induced non-electrolyte pathway in red cells from sickle cell patients.
abstract: Red cells from patients with sickle cell disease contain HbS rather than the normal HbA (here termed HbS cells). On deoxygenation, HbS cells exhibit a distinctive solute permeability pathway, P(sickle), activated stochastically, and partially inhibited by DIDS and dipyridamole. It is often referred to as a cation channel although its permeability characteristics remain vague and its molecular identity is unknown. We show that, in contrast to normal red cells, a proportion of HbS cells underwent haemolysis when deoxygenated in isosmotic non-electrolyte solutions. Haemolysis was stochastic: cells unlysed after an initial deoxygenation pulse showed lysis when harvested, reoxygenated and subsequently exposed to a second period of deoxygenation. O(2) dependence of haemolysis was similar to that of P(sickle) activation. Haemolysis was accompanied by high rates of sucrose influx, and both haemolysis and sucrose influx were inhibited by DIDS and dipyridamole. Sucrose influx was only detected as ionic strength was reduced below 80 mM. These findings are consistent with the postulate that deoxygenation of HbS cells, under certain conditions, activates a novel non-electrolyte pathway. Their significance lies in understanding the nature of the deoxygenation-induced permeability in HbS cells, together with its relationship with novel pathways induced by a variety of manipulations in normal red cells.
authors.affiliation: Department of Physiology, Anatomy and Genetics, Sherrington Building, Oxford.
authors.forename: Joseph A
authors.initials: JA
authors.lastname: Browning
authors.forename: Hannah C
authors.initials: HC
authors.lastname: Robinson
authors.forename: J Clive
authors.initials: JC
authors.lastname: Ellory
authors.forename: John S
authors.initials: JS
authors.lastname: Gibson
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood*; D016022:Case-Control Studies; D004912:Erythrocytes / Q000378:metabolism*; D004913:Erythrocytes, Abnormal / Q000378:metabolism*; D006451:Hemoglobin, Sickle / Q000378:metabolism*; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D007552:Isotonic Solutions / Q000494:pharmacology; D010100:Oxygen / Q000494:pharmacology*; D010539:Permeability / Q000187:drug effects; D015398:Signal Transduction; D013269:Stochastic Processes; D013395:Sucrose / Q000378:metabolism / Q000494:pharmacology
chemical_list: D006451:Hemoglobin, Sickle; D007552:Isotonic Solutions; D013395:Sucrose; D010100:Oxygen